Human Immunodeficiency Virus Infection-Related Heart Disease

Area of Science:

• Cardiology
• Infectious Diseases
• Pharmacology

Background:

• Human immunodeficiency virus (HIV) infection is a significant risk factor for cardiovascular disease (CVD).
• Antiretroviral medications, while life-saving, also contribute to CVD risk.
• The shift from opportunistic infections to chronic CVD in the post-ART era necessitates a focus on cardiac health in HIV patients.

Purpose of the Study:

• To provide a comprehensive overview of cardiovascular disease in HIV-infected individuals.
• To detail the clinical presentation, diagnostic workup, and management strategies for CVD in this population.
• To highlight the evolving landscape of HIV-related comorbidities, emphasizing cardiovascular complications.

Main Methods:

• Review of current literature on HIV and cardiovascular disease.
• Analysis of clinical presentations and diagnostic approaches.
• Synthesis of established and emerging treatment guidelines for managing CVD in HIV patients.

Main Results:

• HIV infection and antiretroviral therapy (ART) are independent risk factors for various cardiovascular conditions.
• Post-ART, HIV patients exhibit increased incidence of acute coronary syndrome, coronary artery disease, arrhythmias, and cardiomyopathy.
• Vague symptoms like fatigue and dyspnea can be initial indicators of CVD in HIV patients.

Conclusions:

• Cardiovascular disease is a major concern for individuals with HIV, particularly in the era of effective ART.
• Early recognition and proactive management of CVD are crucial for improving outcomes in HIV-positive patients.
• A multidisciplinary approach integrating infectious disease and cardiology expertise is essential for optimal patient care.